The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.
The Publisher report includes an overview of the development of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry chain, the market status of Medical Imaging (11C, 13N), Scientific Research (11C, 13N), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PET Radioisotope (Radiopharmaceuticals in PET Imaging).
Regionally, the report analyzes the PET Radioisotope (Radiopharmaceuticals in PET Imaging) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PET Radioisotope (Radiopharmaceuticals in PET Imaging) industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., 11C, 13N).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.
Regional Analysis: The report involves examining the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to PET Radioisotope (Radiopharmaceuticals in PET Imaging):
Company Analysis: Report covers individual PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PET Radioisotope (Radiopharmaceuticals in PET Imaging) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Imaging, Scientific Research).
Technology Analysis: Report covers specific technologies relevant to PET Radioisotope (Radiopharmaceuticals in PET Imaging). It assesses the current state, advancements, and potential future developments in PET Radioisotope (Radiopharmaceuticals in PET Imaging) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PET Radioisotope (Radiopharmaceuticals in PET Imaging) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
PET Radioisotope (Radiopharmaceuticals in PET Imaging) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
11C
13N
150
18F
Others
麻豆原创 segment by Application
Medical Imaging
Scientific Research
Major players covered
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PET Radioisotope (Radiopharmaceuticals in PET Imaging) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), with price, sales, revenue and global market share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) from 2019 to 2024.
Chapter 3, the PET Radioisotope (Radiopharmaceuticals in PET Imaging) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PET Radioisotope (Radiopharmaceuticals in PET Imaging) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PET Radioisotope (Radiopharmaceuticals in PET Imaging) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PET Radioisotope (Radiopharmaceuticals in PET Imaging).
Chapter 14 and 15, to describe PET Radioisotope (Radiopharmaceuticals in PET Imaging) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 11C
1.3.3 13N
1.3.4 150
1.3.5 18F
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Medical Imaging
1.4.3 Scientific Research
1.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size & Forecast
1.5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity (2019-2030)
1.5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (2019-2030)
2 Manufacturers Profiles
2.1 IBA Molecular
2.1.1 IBA Molecular Details
2.1.2 IBA Molecular Major Business
2.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.1.4 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 IBA Molecular Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.2.4 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.3.4 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.4.4 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments/Updates
2.5 Mallinckrodt Pharmaceuticals
2.5.1 Mallinckrodt Pharmaceuticals Details
2.5.2 Mallinckrodt Pharmaceuticals Major Business
2.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.5.4 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.6 Blue Earth Diagnostics
2.6.1 Blue Earth Diagnostics Details
2.6.2 Blue Earth Diagnostics Major Business
2.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.6.4 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Blue Earth Diagnostics Recent Developments/Updates
2.7 ANSTO
2.7.1 ANSTO Details
2.7.2 ANSTO Major Business
2.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.7.4 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 ANSTO Recent Developments/Updates
2.8 ROSATOM
2.8.1 ROSATOM Details
2.8.2 ROSATOM Major Business
2.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
2.8.4 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 ROSATOM Recent Developments/Updates
3 Competitive Environment: PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer
3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Manufacturer (2019-2024)
3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue by Manufacturer (2019-2024)
3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturer 麻豆原创 Share in 2023
3.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创: Overall Company Footprint Analysis
3.5.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创: Region Footprint
3.5.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创: Company Product Type Footprint
3.5.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Region
4.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2030)
4.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2030)
4.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2030)
4.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
4.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
4.4 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
4.5 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
4.6 Middle East and Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Type (2019-2030)
5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Application (2019-2030)
6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030)
7 North America
7.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
7.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
7.3 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Country
7.3.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
7.3.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
8.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
8.3 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Country
8.3.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
8.3.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Region
9.3.1 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
10.2 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
10.3 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Country
10.3.1 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
10.3.2 South America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Size by Country
11.3.1 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Drivers
12.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) 麻豆原创 Restraints
12.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of PET Radioisotope (Radiopharmaceuticals in PET Imaging) and Key Manufacturers
13.2 Manufacturing Costs Percentage of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
13.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Process
13.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Distributors
14.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
听
听
*If Applicable.
